|
US 12,351,653 B1 |
|
| Pharmaceutical compositions comprising novel cyclic peptides |
| Harri Jarvelainen, Tampere (FI); and Erkki Ruoslahti, Rancho Santa Fe, CA (US) |
| Assigned to LISATA THERAPEUTICS, INC. |
| Filed by LISATA THERAPEUTICS, INC., Basking Ridge, NJ (US) |
| Filed on Jan. 15, 2025, as Appl. No. 19/023,048. |
| Application 19/023,048 is a continuation in part of application No. 19/018,888, filed on Jan. 13, 2025. |
| Application 19/018,888 is a continuation of application No. 17/737,008, filed on May 4, 2022, abandoned. |
| Application 19/023,048 is a continuation in part of application No. 17/923,408, previously published as PCT/US2021/030740, filed on May 4, 2021. |
| Application 19/023,048 is a continuation in part of application No. 16/812,107, filed on Mar. 6, 2020. |
| Claims priority of provisional application 63/184,198, filed on May 4, 2021. |
| Claims priority of provisional application 63/329,321, filed on Apr. 8, 2022. |
| Claims priority of provisional application 63/019,799, filed on May 4, 2020. |
| Claims priority of provisional application 62/815,917, filed on Mar. 8, 2019. |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 7/64 (2006.01); A61K 38/12 (2006.01); A61K 45/06 (2006.01) |
